Kristine Aasebø

High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort

Halfdan Sørbye, Anca Dragomir, Magnus Sundström et al. · PLoS ONE · 2015 · 116 citations · Full text

Medicine, Molecular Medicine, Oncology +17

CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup

Kristine Aasebø, Anca Dragomir, Magnus Sundström et al. · Frontiers in Oncology · 2020 · 66 citations · Full text

Medicine, Oncology, Pathology +17

Consequences of a high incidence of microsatellite instability and <i>BRAF‐</i>mutated tumors: A population‐based cohort of metastatic colorectal cancer patients

Kristine Aasebø, Anca Dragomir, Magnus Sundström et al. · Cancer Medicine · 2019 · 52 citations · Full text

Medicine, Cancer Biology, Oncology +17

Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis

Luís Nunes, Kristine Aasebø, Lucy Mathot et al. · Acta Oncologica · 2020 · 40 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway

Åslaug Helland, Hege G. Russnes, Gro Live Fagereng et al. · Journal of Translational Medicine · 2022 · 27 citations · Full text

Medicine, Oncology, Pharmacology +16